VCELVericel
49.2901.790+3.77%195.43K9.61M47.86047.50049.68047.5802.42B2.39B49.03M48.57M+6.50%+8.09%-5.79%+5.46%+10.10%+51.75%+38.42%--0.40%4929.00Loss4.42%Biotechnology
ADAPAdaptimmune Therapeutics
1.2100.040+3.42%1.06M1.28M1.1601.1701.2301.160309.45M206.37M255.75M170.55M+12.04%+21.91%-12.95%+19.80%-18.24%+55.13%+52.59%--0.62%LossLoss5.98%Biotechnology
INCYIncyte
64.1401.120+1.78%1.57M100.35M63.52063.02064.46063.05012.35B10.29B192.60M160.46M+3.19%+5.01%-6.52%+12.68%+7.40%+0.44%+2.15%--0.98%156.4424.202.24%Biotechnology
BLUEbluebird bio
0.6890.012+1.73%4.79M3.31M0.6900.6770.7100.665132.74M132.15M192.74M191.89M-2.88%-30.85%-43.55%-23.60%-54.99%-81.83%-50.09%--2.50%LossLoss6.65%Biotechnology
GSKGlaxoSmithKline
42.6300.680+1.62%3.78M160.87M42.27041.95042.64042.12086.94B84.16B2.04B1.97B+3.27%+6.88%+7.96%-2.82%+2.25%+27.34%+18.24%3.48%0.19%16.6813.581.24%Drug Manufacturers - General
AMGNAmgen
328.8004.270+1.32%1.77M583.40M326.270324.530331.290325.380176.67B176.19B537.33M535.85M+2.29%+2.67%-1.12%+11.72%+19.35%+32.11%+16.68%2.66%0.33%56.6926.331.82%Drug Manufacturers - General
JNJJohnson & Johnson
164.1301.780+1.10%7.09M1.16B162.500162.350164.220161.695395.10B394.38B2.41B2.40B+2.97%+2.19%+2.17%+13.63%+3.51%+1.08%+6.36%2.93%0.30%10.9011.961.56%Drug Manufacturers - General
GILDGilead Sciences
76.7200.820+1.08%6.85M525.65M76.09075.90077.12075.91095.52B95.33B1.24B1.24B+3.98%+4.15%-0.38%+22.30%+8.59%+4.02%-3.15%3.96%0.55%93.5617.051.59%Drug Manufacturers - General
NVSNovartis AG
118.5600.800+0.68%801.21K94.67M117.940117.760118.590117.710240.03B229.20B2.02B1.93B+3.37%+5.96%+7.47%+19.32%+20.67%+27.61%+21.86%3.19%0.04%15.2016.700.75%Drug Manufacturers - General
PFEPfizer
28.9000.120+0.42%21.89M631.18M28.82028.78028.94028.640163.77B163.54B5.67B5.66B+2.12%+1.23%-6.08%+5.35%+14.91%-15.87%+4.89%5.74%0.39%Loss78.111.04%Drug Manufacturers - General
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.